A recent RISE Health webinar examined how the Clover Health v. HHS decision could reshape CMS’s authority over Star Ratings, quality measures and billions in Medicare Advantage payments.
Could a Court Ruling Upend Medicare Advantage Star Ratings?
June 9, 2026
- GSK Gets a Pair of Near-Commercial Lung Cancer Drugs via $10.6B Nuvalent Acquisition
- Healthcare’s Assurance Infrastructure Is Broken. The Compliance Industry Built It That Way
- Bridging Movement and Machine Learning: How Clinicians Can Harness AI in Practice
- GLP-1s Are a $70 Billion Market — So Why Are Patients Still Getting Medical Advice From TikTok Influencers?
Headlines
